Microbix Biosystems Q1 2023 Earnings Report C$0.40 +0.03 (+8.11%) (As of 12/20/2024 05:17 PM ET) Earnings HistoryForecast Microbix Biosystems EPS ResultsActual EPS-C$0.01Consensus EPS -C$0.01Beat/MissMet ExpectationsOne Year Ago EPSN/AMicrobix Biosystems Revenue ResultsActual Revenue$2.50 millionExpected Revenue$2.80 millionBeat/MissMissed by -$300.00 thousandYoY Revenue GrowthN/AMicrobix Biosystems Announcement DetailsQuarterQ1 2023Date2/9/2023TimeN/AConference Call ResourcesMBX Earnings History First JFK… next Elon? (Ad)Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. Microbix Biosystems Earnings HeadlinesMicrobix Biosystems Inc.: Microbix Reports Record Product Sales for Q4 and Fiscal 2024December 19 at 1:08 PM | finanznachrichten.deMicrobix Biosystems Reports Record Revenue GrowthDecember 19 at 7:53 AM | tipranks.com⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.December 22, 2024 | Behind the Markets (Ad)Microbix Reports Record Product Sales for Q4 and Fiscal 2024December 19 at 7:32 AM | financialpost.comMicrobix Schedules Release of Results for Q4 Fiscal 2024December 12, 2024 | markets.businessinsider.comMicrobix Assisting EMQN with Novel Genetic-Test EQA ProgramDecember 10, 2024 | markets.businessinsider.comSee More Microbix Biosystems Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Microbix Biosystems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Microbix Biosystems and other key companies, straight to your email. Email Address About Microbix BiosystemsMicrobix Biosystems (TSE:MBX), a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.View Microbix Biosystems ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings Upcoming Earnings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
